Researchers at the University of Wyoming are designing a higher-accuracy flu test that has undergone preliminary human ...

The FDA has approved Freenome's blood-based colorectal cancer screening ​test for older adults, paving the way for partner ...

The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S. Abbott will pay Freenome $100 million as part of a 2025 deal ...

Freenome's newly approved blood test offers clinicians an alternative screening option for average-risk adults aged 45 and ...

The MassTrak LC-MS/MS IVD System with the Xevo TQ Absolute XR Mass Spectrometer is available to order now. Xevo, StepWave, ...

A single blood test that looks for signs of more than 50 types of cancer sounds revolutionary. But experts say it's important ...

A blood test originally developed for humans and validated for use in horses by researchers at the University of Calgary is ...

The Financial Sector Assessment Program (FSAP) for Portugal conducted a comprehensive systemic risk analysis and assessment of the resilience of the banking sector. This included a full-fledged ...

Red meat allergy from tick bites—alpha-gal syndrome—may affect up to 450,000 Americans. Learn the causes, symptoms, and how ...

"Laboratories today face growing pressure to deliver faster, more accurate results while managing operational complexity," said Puneet Sarin, senior vice president and president, specialty diagnostics ...

Your ‘normal’ blood work may still hide metabolic risk. Learn more about the key lab markers that can signal issues with your ...

The FDA has approved SimpleScreen CRC, a blood-based colorectal cancer screening test developed by Brisbane, Calif.-based Freenome, on July 27, according to a July 27 news release. This is the second ...